Marker Therapeutics, Inc. Common Stock
MRKR
Closed
$1.54
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
The company is headquartered in Houston, Texas and currently employs 5 full-time employees. The company went IPO on 2016-11-08.
Key stats
Open
$1.57
Volume
38.97K
Market cap
$26.34M
Prev. close
$1.58
Impl / hst vl
-
Open interest
$0.00
$1.51
Day’s Range
$1.60
$1.17
52W Range
$2.46
Valuation
27
Valuation score
Overvalued
P/E
-
P/S
7.43
P/B
1.91
Current ratio
4.79
Debt / Equity
-1.08
ROE
-
Gross margin
-
Income growth
-
FCF growth
-26.10
Analysts estimates
Consensus rating
Buy
The average rating from top 6 analysts indicates that stock is expected to perform in line with the market
Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$8.02
The top 5 analysts forecasts that 12-month price may increase by 421.04%, with a low of $5.66 and a high of $10.50
$5.66
Low
$8.02
Avg
$10.50
High
Current price
Earnings
Q4 ‘25 revenue
$1.10M
Q4 ‘25 net income
-$1.70M
Revenue
Net income
Previous EPS
-$0.16
Estimate EPS
-$0.21
Actual EPS
Estimate EPS
Explore the Healthcare sector
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply